The pharmacy day | A question to investigate
Moving assembly does not move every responsibility
Hub-and-spoke dispensing can be an attractive response to pressure in a pharmacy, but the investment case needs more than a promised reduction in assembly work. Prescriptions still arrive unpredictably, exceptions still require attention and people still need a dependable service. An owner needs to know which work moves, which remains and what new coordination appears. The useful comparison starts with the pharmacy's actual operating pattern rather than a general claim that automation creates efficiency.
In the conversation.
NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.
Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.
Begin with the current legal and service position
The 2025 hub-and-spoke regulations and the accompanying impact assessment provide relevant starting documents for considering these arrangements (Department of Health and Social Care, 2025; Department of Health and Social Care, n.d.). They should be reviewed alongside current NHS service requirements and professional advice for the proposed model. A commercial assessment does not determine whether a particular arrangement is compliant. Its role is to make the operating assumptions inspectable so that legal, professional and business decisions are based on the same description of what is proposed.
Build the exception case before the average case
Identify which prescriptions are suitable for the proposed route and which would remain local. Consider changes after transmission, urgent demand, incomplete orders and interruptions to transport or systems. Record who owns each exception and the fallback available. A high proportion of routine work moving to a hub may still leave the branch with complex, time-sensitive work. That change in case mix can affect staffing and attention differently from the headline reduction in assembled items.
Compare realistic alternatives
The comparator should include the current process and credible local improvements that do not require a hub arrangement. These could involve scheduling or a more reliable internal handover, subject to professional approval. Compare like-for-like service expectations rather than allowing one option to exclude difficult work. The decision may be to adopt, trial a narrower scope, delay or retain local dispensing. An evaluation has value if it makes the choice clearer, even when it weakens the case for a large purchase.
Stress-test three assumptions before commitment
Vary the share of work suitable for the arrangement, the retained local exception effort and the actual use of released capacity. Show a conservative, central and demanding operating scenario using clearly labelled assumptions. If the case works only when every released minute becomes additional paid activity, make that dependency explicit. A sensitivity table can reveal which supplier claim needs verification before an owner spends on integration, training or a contract.
Move assembly. Account for everything.
An investment case gets stronger when it explains the conditions for repetition. Make the next commitment depend on evidence.
A pharmacy is reviewing a hub arrangement before committing. Routine assembly could move, while urgent demand, exceptions and patient contact remain local. The owner needs to know whether the whole operating model is worthwhile.
Supports an investable boundary: suitable now, suitable after a defined dependency, unsuitable under present conditions or still unknown.
What would we need to understand?
- Actual workload suitable for the proposed arrangement
- Retained local exceptions and professional cover
- Supplier terms, transition and recurrent costs
- A workable fallback and use of released capacity
Constructed decision example | No customer results are shown.
A proposed readiness and economics review
A bounded PHARMORIS evaluation could assess one branch or a small group using authorised aggregate workload, actual staffing, supplier terms and a record of exception handling. The first stage would examine feasibility before any operational change. If a live trial were separately agreed, it would require its own governance, responsibilities and fallback plan. The commercial output would distinguish evidenced observations from supplier assumptions and identify the conditions needed for the arrangement to be worthwhile.
Follow all the costs and all the capacity
Include hub charges, transport, packaging, integration, training, transition effort and retained local work. Count staff time released only where a specific task is removed and the remaining rota can use the capacity. An owner continuing to pay the same cover has not necessarily generated cash savings. Additional clinical activity is a separate opportunity that depends on demand, rooms, competence and service requirements. Do not count both hypothetical wage reductions and redeployed activity from the same minutes.
Set the boundaries before commitment
Agree limits for delays, unresolved exceptions, staff burden and service continuity. Stop or narrow the arrangement if the branch cannot maintain an acceptable fallback or the assumptions needed for the business case are not supported. A supplier demonstration is useful evidence of a function, not proof of the pharmacy's operating result. An early review should identify which uncertainties can be resolved through documents and which require a properly authorised test in ordinary conditions.
NEUVIOR Data Analysis
A source.
A question.
A clearer decision.
Useful intelligence keeps its evidence attached.
Our public analysis connects a defined question with named sources, reporting periods and methods. Each source below shows the work available today and the access still needed.
Published-data analysis, research hypotheses and evidence studies are distinct kinds of work. Their meaning should remain clear as the programme grows.
NHS Business Services Authority | Annual
Prescription Cost Analysis
How does activity differ from ingredient-cost concentration?
Analysis availableNHS Business Services Authority | Monthly
English Prescribing Dataset with SNOMED Code
Which product and organisational patterns merit a closer investigation?
Metadata retrievedMedicines and Healthcare products Regulatory Agency | Event-driven; monthly roundup also published
Medicines and device safety communications
Which official communication should a responsible team read next?
Snapshot retrievedNHS Business Services Authority and NHS England | Weekly
Dictionary of medicines and devices
Can the same product identity be followed consistently across sources?
Access reviewBring the decision before buying the promise
The best starting material is a proposed arrangement, an actual cost structure and a clear account of the work the owner wants to improve. We can explore an independent, bounded evaluation that makes the investment case more transparent. PHARMORIS is being developed to support accountable medicines decisions; it should earn a role by helping a pharmacy distinguish a compelling operating change from an attractive model that does not fit its premises, team or demand.
Sources and scope
UK legislation | Hub and spoke dispensing regulations 2025 | DHSC | Hub and spoke dispensing impact assessment
Department of Health and Social Care (2025) Hub and spoke dispensing regulations 2025. Available at: https://www.legislation.gov.uk/uksi/2025/758/contents/made (Accessed: 14 October 2026).
Department of Health and Social Care (n.d.) Hub and spoke dispensing impact assessment. Available at: https://www.legislation.gov.uk/ukia/2025/87/pdfs/ukia_20250087_en.pdf (Accessed: 14 October 2026).
Another useful angle.
- Independent pharmacy | Make the next service earn its place
A practical decision framework for independent owners comparing service demand, capacity, costs and cash before expanding.
- Blood pressure services | Plan capacity through the whole pathway
Explore clinic checks, ambulatory monitoring capacity and handovers as a coherent pharmacy operational question.
- Consultation space | Make capacity useful, not just full
Compare competing uses of pharmacy consultation rooms through demand, professional cover, access and economic contribution.